| 000 | 01530 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513131032.0 | ||
| 264 | 0 | _c19971211 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0960-3271 | ||
| 024 | 7 |
_a10.1177/096032719701601009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBismuth, C | |
| 245 | 0 | 0 |
_aImmunotoxicotherapy: successes, disappointments and hopes. _h[electronic resource] |
| 260 |
_bHuman & experimental toxicology _cOct 1997 |
||
| 300 |
_a602-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Congress | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xpoisoning |
| 650 | 0 | 4 |
_aAntivenins _ximmunology |
| 650 | 0 | 4 |
_aArrhythmias, Cardiac _xchemically induced |
| 650 | 0 | 4 | _aBinding Sites, Antibody |
| 650 | 0 | 4 |
_aColchicine _ximmunology |
| 650 | 0 | 4 |
_aDigoxin _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Passive |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _ximmunology |
| 650 | 0 | 4 |
_aImmunotherapy _xeconomics |
| 650 | 0 | 4 |
_aLipopolysaccharides _xadverse effects |
| 650 | 0 | 4 |
_aPoisoning _xtherapy |
| 650 | 0 | 4 |
_aSepsis _xchemically induced |
| 650 | 0 | 4 |
_aVenoms _xadverse effects |
| 700 | 1 | _aBorron, S W | |
| 700 | 1 | _aBaud, F J | |
| 700 | 1 | _aTaboulet, P | |
| 700 | 1 | _aScherrmann, J M | |
| 773 | 0 |
_tHuman & experimental toxicology _gvol. 16 _gno. 10 _gp. 602-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/096032719701601009 _zAvailable from publisher's website |
| 999 |
_c9333445 _d9333445 |
||